Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis

NCT04863014 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

21

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Hypertriglyceridemia

Interventions

DRUG: evinacumab
OTHER: Placebo

Sponsor

Regeneron Pharmaceuticals